Evidence map›Paper›PMID 29191870›Full record

ArticleAJNR. American journal of neuroradiology2018

Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset.

A Meijerman, H Amiri, M D Steenwijk, M A Jonker, R A van Schijndel, K S Cover, H Vrenken, Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

A MeijermanFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.).ORCID 0000-0003-1554-3940
H AmiriFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.) amiri.houshang@gmail.com.ORCID 0000-0003-4086-5255
M D SteenwijkFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.).ORCID 0000-0002-8346-9044
M A JonkerEpidemiology and Biostatistics (A.M., M.A.J.), Vrije University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-0134-8482
R A van SchijndelFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.).ORCID 0000-0002-2294-1050
K S CoverFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.).ORCID 0000-0002-0111-3395
H VrenkenFrom the Departments of Radiology and Nuclear Medicine (A.M., H.A., M.D.S., R.A.v.S., K.S.C., H.V.).ORCID 0000-0001-9106-1172
Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

background and purposePrecise in vivo measurement of deep GM volume change is a highly demanded prerequisite for an adequate evaluation of disease progression and new treatments. However, quantitative data on the reproducibility of deep GM structure volumetry are not yet available. In this paper we aim to investigate this reproducibility using a large multicenter dataset. MATERIALS AND

methodsWe have assessed the reproducibility of 2 automated segmentation software packages (FreeSurfer and the FMRIB Integrated Registration and Segmentation Tool) by quantifying the volume changes of deep GM structures by using back-to-back MR imaging scans from the Alzheimer Disease Neuroimaging Initiative's multicenter dataset. Five hundred sixty-two subjects with scans at baseline and 1 year were included. Reproducibility was investigated in the bilateral caudate nucleus, putamen, amygdala, globus pallidus, and thalamus by carrying out descriptives as well as multilevel and variance component analysis.

resultsMedian absolute back-to-back differences varied between GM structures, ranging from 59.6-156.4 μL for volume change, and 1.26%-8.63% for percentage volume change. FreeSurfer had a better performance for the outcome of longitudinal volume change for the bilateral amygdala, putamen, left caudate nucleus (

conclusionsLongitudinal deep GM atrophy measures should be interpreted with caution. Furthermore, deep GM atrophy measurement techniques require substantially improved reproducibility, specifically when aiming for personalized medicine.

Indexed as

AdultAlzheimer DiseaseAtrophyBrainDatasets as TopicDisease ProgressionFemaleGray MatterHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingReproducibility of ResultsSoftware

Identifiers

PMID29191870
PMCPMC7410697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.